BioNexus Gene Lab Corp Common stock (BGLC)
Official siteBASIC MATERIALS • SPECIALTY CHEMICALS • NASDAQ
Market Cap: $2.41M
Last updated: Nov 17, 2026 at 4:10 PM ET
BioNexus Gene Lab Corp Common stock (BGLC) Stock Chart
BioNexus Gene Lab Corp Common stock (BGLC) has a latest price of $0.77 on Nov 17, 2026. Its price fell 83.1% over the past 12 months. The month-end price fell 99.6% over the 5 years through Oct 2026, a compound annual decline of 66.8%.
Price Chart
From Sep 2020 to Oct 2026, its highest month-end close was $330.13 in Nov 2020 and its lowest $0.92 in Oct 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart BGLC with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for BGLC.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 51.2%, and over 6 months it fell 63.5%. The month-end price fell 78.1% over the 3 years through Oct 2026, a compound annual decline of 39.7%.
| Period | Change |
|---|---|
| 1 month | -37.6% |
| 3 months | -51.2% |
| 6 months | -63.5% |
| 12 months | -83.1% |
| 12 months, with dividends | -83.1% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -78.1% | -39.7% |
| 5 years | -99.6% | -66.8% |
Price by Year
Its best calendar year was 2025, when the price rose 41.2%, and its weakest was 2023, when it fell 95.4%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $0.92 | -76.8% |
| 2025 | $3.95 | +41.2% |
| 2024 | $2.80 | -47.2% |
| 2023 | $5.30 | -95.4% |
| 2022 | $114.05 | -55.4% |
| 2021 | $255.70 | -7.4% |
Trading Range
The price is 36.2% below its 50-day average of $1.20 and 58.1% below its 200-day average of $1.83.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $0.77 | |
| 50-day average | $1.20 | -36.2% |
| 200-day average | $1.83 | -58.1% |
Price Risk
Over 3 years, its largest fall from a peak was 95.1%.
| Measure | Value |
|---|---|
| 1-year beta | 1.55 |
| Largest fall, 1 year | -84.1% |
| Largest fall, 3 years | -95.1% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About BGLC
What is BGLC's 1-year price change?
BioNexus Gene Lab Corp Common stock's price fell 83.1% over the past 12 months. With dividends included, the 12-month total return was -83.1%.
What is BGLC's 5-year price change?
BioNexus Gene Lab Corp Common stock's month-end price fell 99.6% over the 5 years through Oct 2026, a compound annual decline of 66.8%. These figures leave out dividends.
What is BGLC's beta?
BioNexus Gene Lab Corp Common stock's 1-year beta against the S&P 500 is 1.55, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 84.1%.
Is the BGLC chart free?
Yes. Advanced Charting for BGLC is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
BGLC pages: Overview, Charting, Financials, Statistics